An Electrochemical Immunosensor Based on GO@CS for Highly Sensitive and Accurate Detection of Cardiovascular Markers-cTn- I

The hidden hazards of cardiovascular diseases (CVDs) are enormous, and there is a lack of early warning and prognostic risk assessment technologies. In this study, Cardiac troponin I (cTn-I), the “gold standard” for CVDs diagnosis, was selected as the target molecule, and chitosan functionalized gra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Electrochemical Society 2023-11, Vol.170 (11), p.117502
Hauptverfasser: Sun, Bolu, Kan, Lei, Liu, Yuhong, Sun, Yanlei, Liu, Jinhai, Wu, Yuqiong, Li, Huajie, Yu, Shixing, Bao, Liangrong, Gao, Chengyang, Yang, Yanmei, Yang, Lin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The hidden hazards of cardiovascular diseases (CVDs) are enormous, and there is a lack of early warning and prognostic risk assessment technologies. In this study, Cardiac troponin I (cTn-I), the “gold standard” for CVDs diagnosis, was selected as the target molecule, and chitosan functionalized graphene oxide composites (GO@CS) with excellent electrochemical performance were prepared as the electrode base material. Gold nanoparticles (AuNPs) were deposited on GO@CS by electrochemical deposition. Due to the large surface area, excellent electrical conductivity and good biocompatibility of GO@CS assembled with AuNPs provide abundant active sites for the immobilization of cTn-I antigen. Under the optimized experimental conditions, the fabricated immunosensor had a wide linear range of 2.44 × 10 −2 ng ml −1 to 2.50 × 10 ng ml −1 and a low detection limit of 1.12 × 10 −2 ng ml −1 (S/N = 3). This study achieves the highly sensitive identification and detection of trace amounts of cTn-I in complex biological samples, providing a convenient and efficient method for the detection of CVDs-related markers. It also provides a scientific basis, new technologies and new methods for the development of objective early warning techniques for CVDs and the study of related pathological mechanisms. A highly sensitive and rapid electrochemical immunosensor for the determination of CVDs-biomarker-cTn-I in whole serum samples has been fabricated. The prepared AuNPs@GO@CS with a large specific surface area and excellent electrical conductivity can amplify the signal of the immunosensor. This method with high selectivity, low-cost, reproducibility and stability would provide a promising potential in early clinical screening and diagnosis of CVDs.
ISSN:0013-4651
1945-7111
DOI:10.1149/1945-7111/ad066a